Vimarsana
Biggest News Aggregation in the World

Biomedical Enterprise Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomedical Enterprise Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomedical Enterprise Program Today - Breaking & Trending Today

Richard Cohen: Pioneering biomedical research and education at MIT for half a century - Vimarsana News

Richard Cohen: Pioneering biomedical research and education at MIT for half a century

Physician, scientist, and professor Richard J. Cohen has made influential contributions to the Harvard-MIT Program in Health Sciences and Technology since it began 50 years ago. He will transition to emeritus status in March.

Source: mit.edu
Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc - Vimarsana News

Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc

IRVINE, Calif., Jan. 03, 2022 -- Clinical Laserthermia Systems AB , developer of high precision, image-guided focal laser ablation systems, today announced it has promoted Mr. Michael Magnani to... | January 3, 2022

Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc - Vimarsana News

Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc

Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc - read this article along with other careers information, tips and advice on BioSpace

Avidity Biosciences Announces Changes to its Board of Directors - Vimarsana News

Avidity Biosciences Announces Changes to its Board of Directors

Avidity Biosciences Announces Changes to its Board of Directors Tamar Thompson and Jean Kim appointed to Board of Directors replacing Todd Brady and Michael Martin News provided by Share this article Share this article LA JOLLA, Calif., Jan. 11, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs ™), today announced the appointment of experienced health policy strategist, Tamar Thompson and recognized healthcare investment partner, Jean Kim, to its...